User talk:Thurayya Faruk

Taking birth control pills more than doubles brain tumor risk in five years
Women who take birth control pills will not be pleased with a recent discovery that suggests a link between taking the contraceptive and brain tumor development.

Danish researchers have discovered that taking a birth control pill for over five years can more than double the risk of developing a rare form of brain cancer, glioma. The experts analyzed over 300 women who had been diagnosed with glioma over the course of nine years, ultimately discovering that the women who were using progestogen-only birth control methods had a brain tumor risk that was 2.4 times higher than that of the control group.

Team leader Dr. David Gaist, with Odense University Hospital and the University of Southern Denmark, said, "In a population of women in the reproductive age, including those who use hormonal contraceptives, you would anticipate seeing 5 in 100,000 people develop a glioma annually." He feels the study is important, noting that it's "an important contribution and we hope that our findings will spark further research on the relationship between female hormonal agents and glioma risk."

"Two-fold" risk of developing brain tumor The study, titled, "Hormonal contraceptive use and risk of glioma among younger women a nationwide case-control study," was published in the British Journal of Clinical Pharmacology.

It states:

Oral contraceptive use influences the risk for certain cancers; however, few studies have examined any link with risk of central nervous system tumors. We investigated the association between hormonal contraceptive use and glioma risk among premenopausal women in a population-based setting.

The web page for the study states:

In this Danish registry-based study, we found that ever use of hormonal contraceptives was associated with a moderately increased risk of glioma among younger women.

A nearly two-fold increased risk of glioma was observed among long-term users of hormonal contraceptives.

According to neurosurgeons at the University of California, Los Angeles, a glioma is a primary brain tumor that develops from glial cells, which are the brain's supportive cells. Glial cells differ from neurons in that they have the ability to divide and multiply. In the event of this occurring too rapidly, a person may develop a glioma.

Taking birth control pills more than doubles brain tumor risk in five years
From Wikipedia, the free encyclopedia

Oral contraceptives, abbreviated OCPs, also known as birth control pills, are medications taken by mouth for the purpose of birth control.

Two types of female oral contraceptive pill, taken once per day, are widely available:

The combined oral contraceptive pill contains estrogen and progestin The progestin-only pill

Emergency contraception pills ("morning after pills") are taken at the time of intercourse, or within a few days afterwards.

Yuzpe regimen uses combined oral contraceptives Ulipristal acetate is an antiprogestogen

Other types of female oral contraceptive are experimental or only available in limited areas:

Mifepristone is an antiprogestogen which has been used as a daily oral contraceptive in investigational clinical trials Ormeloxifene (also known as Centchroman) is a selective estrogen receptor modulator which is taken one to two times per week

Women who take birth control pills will not be pleased with a recent discovery that suggests a link between taking the contraceptive and brain tumor development.

Danish researchers have discovered that taking a birth control pill for over five years can more than double the risk of developing a rare form of brain cancer, glioma. The experts analyzed over 300 women who had been diagnosed with glioma over the course of nine years, ultimately discovering that the women who were using progestogen-only birth control methods had a brain tumor risk that was 2.4 times higher than that of the control group.

Team leader Dr. David Gaist, with Odense University Hospital and the University of Southern Denmark, said, "In a population of women in the reproductive age, including those who use hormonal contraceptives, you would anticipate seeing 5 in 100,000 people develop a glioma annually." He feels the study is important, noting that it's "an important contribution and we hope that our findings will spark further research on the relationship between female hormonal agents and glioma risk."

"Two-fold" risk of developing brain tumor The study, titled, "Hormonal contraceptive use and risk of glioma among younger women a nationwide case-control study," was published in the British Journal of Clinical Pharmacology.

It states:

Oral contraceptive use influences the risk for certain cancers; however, few studies have examined any link with risk of central nervous system tumors. We investigated the association between hormonal contraceptive use and glioma risk among premenopausal women in a population-based setting.

The web page for the study states:

In this Danish registry-based study, we found that ever use of hormonal contraceptives was associated with a moderately increased risk of glioma among younger women.

A nearly two-fold increased risk of glioma was observed among long-term users of hormonal contraceptives.

According to neurosurgeons at the University of California, Los Angeles, a glioma is a primary brain tumor that develops from glial cells, which are the brain's supportive cells. Glial cells differ from neurons in that they have the ability to divide and multiply. In the event of this occurring too rapidly, a person may develop a glioma.